Fish Oil Supplements May Interfere with Chemotherapy

Some fish-oil supplements interfere with chemotherapy metabolism and should therefore not be taken during chemotherapy treatment or they can render it less effective, according to new research.

Some fish-oil supplements appear to allow cancer cells to reassemble following treatment, according to a study in the Netherlands, published by the journal JAMA Oncology. Researchers there looked at blood levels of a particular type of fatty acid suspected of interfering with cancer treatment – one of the so-called omega-3 oils found in fish.

Tests showed elevated levels of fatty acid

Blood tests performed on healthy volunteers who took fish-oil supplements showed elevated levels of the specific fatty acid persisted for at least eight hours and sometimes much longer, depending on the amount of fish oil that was consumed.

Thus, researchers are recommending that patients consider avoiding fish oil on the day before and the day after any chemotherapy treatments. They also advised against eating oily fish such as herring or mackerel during that very same 48-hour period.

Ultimately, each patient should discuss this with their oncology team first and make a collective decision on whether or not to take fish oil supplements, and when.

Fish-oil supplements are extremely popular supplements in the US and worldwide, taken both by healthy people as well as those with cancer. Many regard these supplements as being an important part of lifestyle changes that will benefit their health in the present and future.

Source: JAMA Oncology

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap